Navigation Links
Most men with low-risk prostate cancer receive aggressive treatment
Date:7/26/2010

Most men who are diagnosed with prostate cancer appear to under undergo aggressive therapy, even if they have a low prostate-specific antigen (PSA) level and low-risk disease, according to a report in the July 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

More than 90 percent of all prostate cancers are diagnosed before the disease has spread to other parts of the body, and the five-year survival rate for these patients diagnosed with localized disease is almost 100 percent, according to background information in the article. The five-year survival rate from all stages of disease increased from 69 percent in 1975 to almost 99 percent in 2003. "The tremendous improvement in survival has been attributed to early detection and treatment," the authors write. "However, there have been concerns about the potential overdiagnosis and overtreatment of localized prostate cancer. Despite these concerns, some researchers argue that the prostate-specific antigen (PSA) level is associated with a continuum of cancer risk and recommend lowering the 4-nanogram per milliliter threshold for biopsy."

To determine current risk profiles and treatment patterns of men with prostate cancer and PSA levels below this threshold, Yu-Hsuan Shao, Ph.D., of the Cancer Institute of New Jersey, New Brunswick, and colleagues used data from the Surveillance, Epidemiology and End Results system. Of 123,934 men with newly diagnosed prostate cancer from 2004 to 2006, 14 percent had PSA levels of 4 nanograms per milliliter or lower. "The patients in these cases were less likely to have high-grade cancer, and more than half were classified as having low-risk cancer," the authors write.

"Despite their lower risk of having clinically significant disease, treatment rates for men with PSA values of 4.0 nanograms per milliliter or lower were comparable to those of men presenting with PSA values between 4.0 and 20.0 nanograms per milliliter.
'/>"/>

Contact: Michele Fisher
fisherm2@umdnj.edu
732-235-9872
JAMA and Archives Journals
Source:Eurekalert

Page: 1 2

Related medicine news :

1. What is the role of focal therapy in low-risk prostate cancer?
2. Value of Monitoring Low-Risk Prostate Cancer Assessed
3. Delay in surgery not likely to worsen tumors in men with low-risk prostate cancer
4. Surveillance may be suitable treatment option for patients with low-risk prostate cancer
5. Advance Toward Test for Aggressive Prostate Cancer
6. DASH FOR DAD Race Series Coming to 11 Cities to Raise Prostate Cancer Awareness
7. Jim Huber to Serve as National Spokesman for Know Your Score: Fight Prostate Campaign at Myrtle Beach Golf Holiday in August
8. Few differences in outcomes between open and laparoscopic prostate surgery
9. Two Surgical Methods Equally Successful for Prostate Cancer
10. Genetic Mutation Linked to Prostate Cancer in Blacks
11. Statins May Benefit Prostate Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... 01, 2014 An operating theatre or ... for performing surgical operations. An operating room comprises a ... booms, operating room lights, imaging displays as well as ... by Transparency Market Research, a U.S.-based market research firm, ... USD 4.5 billion by 2019. , According to ...
(Date:9/1/2014)... September 2014: Daily fruit consumption cuts the risk of ... research presented at ESC Congress today by Dr Huaidong ... year follow-up study of nearly 0.5 million people in ... people ate, the more their risk of CVD declined. ... (IHD) and stroke, is the leading cause of death ...
(Date:9/1/2014)... New York (PRWEB) September 01, 2014 ... store, retrieve, organize and analyze biological and genetic ... of the activity of developing software tools to ... not to be confused with biological computation. While ... better understanding of biology can its related concepts, ...
(Date:9/1/2014)... September 01, 2014 Ontraport , ... marketers that was developed to automate the small intricacies ... attention of Shane Michaels, prompting an investigative review. ... daily duty of managing all of the small details ... quite overwhelming,” reports Michaels. “That’s why Ontraport has become ...
(Date:9/1/2014)... Aliso Viejo, California (PRWEB) September 01, 2014 ... of a new tutorial video for the ProWorld Plugin from ... what Final Cut Pro X can do and users now ... own HDRI images.” Said Christina Austin, CEO of Pixel Film ... a definite game changer.” , Learn how to turn a ...
Breaking Medicine News(10 mins):Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 2Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 3Health News:Fruit consumption cuts CVD risk by up to 40 percent 2Health News:Fruit consumption cuts CVD risk by up to 40 percent 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Ontraport: Review Exposes Automated Platform for Online Marketing Management 2Health News:Pixel Film Studios Released a New Tutorial Entitled ProWorld Lesson Exclusively for Final Cut Pro X 2
... (HealthDay News) -- Scientists say they,ve learned why a ... bland supermarket variety. The University of Florida researchers ... heirloom varieties, most of which were bred before today,s ... large chemical diversity. The researchers than had ...
... News) -- Women with advanced breast cancer who have higher ... women with lower levels of fitness during treatment, new research ... and lung function, according to the study by researchers at ... years after treatment has ended. Among those with advanced ...
... News) -- Only one in 14 Hispanic adults in the ... fewer than the one in four whites screened, a new ... insurance and poorer access to health care services are major ... Cancer Institute of New Jersey. They added that their ...
... from the University of California, San Diego and its ... in new grants from the California Institute for Regenerative ... spinal cord injuries, repairing gene mutations that cause amyotrophic ... failure and Alzheimer,s disease. The awards mark the ...
... An overactive BAALC gene in acute leukemia cells identifies patients ... This study discovered why the gene is often overactive., ... guide therapy in these patients. COLUMBUS, Ohio ... overactivating a gene linked to poor treatment response in people ...
... YORK, May 25, 2012 Ben-Gurion University of the ... the desert with the successful application of a solar-powered ... regions. The project was made possible with support from ... The solar-powered system uses nanofiltration membranes to treat the ...
Cached Medicine News:Health News:Fitness May Boost Survival for Women With Breast Cancer 2Health News:Few U.S. Hispanics Screened for Skin Cancer 2Health News:UC San Diego researchers receive new CIRM funding 2Health News:UC San Diego researchers receive new CIRM funding 3Health News:Inherited DNA change explains overactive leukemia gene 2Health News:Ben-Gurion U. researchers successfully test solar desalination system for arid land agriculture 2
(Date:8/29/2014)... 29, 2014 Research and Markets  has announced ... Insight 2014" report to their offering. ... one of the largest segments of pharmaceuticals industry. The numbers ... the available therapies were unable to meet the market requirements. ... for CNS disorder, especially over the past two decades. The ...
(Date:8/29/2014)... Md. , Aug. 29, 2014  United Therapeutics ... the U.S. District Court for the District of ... favor in the company,s case against Sandoz, Inc. regarding ... Peter Sheridan ruled that U.S. Patent No. ... and enjoined Sandoz from marketing its generic product until ...
(Date:8/29/2014)...  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... to release its financial results for the fiscal 2014 ... market trading ends on Tuesday, September 9, 2014. ... 4:30 p.m. U.S. EDT on Tuesday, September 9, 2014 ... the Company,s financial results, commercial partnerships, and future outlook.  ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2
... 2011 Express Scripts (Nasdaq: ESRX ), one ... announced today its intention to release its third quarter earnings ... will hold its quarterly conference call to discuss third quarter ... Time (8:30 a.m. Central Time). This call is ...
... U.S. Food and Drug Administration has issued a proposed ... classification for external pacemaker pulse generators from Class III ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) External pacemaker pulse generators are ... permanent pacemaker can be implanted. They are also used ...
Cached Medicine Technology:FDA Proposes Lower Risk Classification, Special Controls for External Pacemakers 2FDA Proposes Lower Risk Classification, Special Controls for External Pacemakers 3
Curved shafts with 0.5 mm, 1 x 2 teeth. Serrated handle with thumb catch lock and polished finish....
Narrow 12 mm jaws with fine teeth. Serrated handle with polished finish....
Straight shafts with heavy Elschnig teeth. Flat serrated handle with slide style lock and polished finished....
Straight shafts with delicate 0.7 mm, 1 x 2 teeth. Serrated handle with polished finish....
Medicine Products: